These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9086147)

  • 1. Novel anti-Pneumocystis carinii effects of the immunosuppressant mycophenolate mofetil in contrast to provocative effects of tacrolimus, sirolimus, and dexamethasone.
    Oz HS; Hughes WT
    J Infect Dis; 1997 Apr; 175(4):901-4. PubMed ID: 9086147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Provocative effects of the immunosuppressants rapamycin, tacrolimus, and dexamethasone on pneumonitis in contrast to the anti- pneumonitis effects of mycophenolate mofetil.
    Oz HS; Hughes WT; Varilek G
    Transplantation; 2001 Oct; 72(8):1464-5. PubMed ID: 11685124
    [No Abstract]   [Full Text] [Related]  

  • 3. Mycophenolate mofetil inhibits intimal hyperplasia and attenuates the expression of genes favouring smooth muscle cell proliferation and migration.
    Waller JR; Brook NR; Bicknell GR; Murphy GJ; Nicholson ML
    Transplant Proc; 2005; 37(1):164-6. PubMed ID: 15808582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanisms of action of new xenobiotic immunosuppressive drugs: tacrolimus (FK506), sirolimus (rapamycin), mycophenolate mofetil and leflunomide.
    Brazelton TR; Morris RE
    Curr Opin Immunol; 1996 Oct; 8(5):710-20. PubMed ID: 8902398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutagenic and cytotoxic effects of immunosuppressive drugs on human lymphocyte cultures.
    Oliveira VD; Zankl H; Rath T
    Exp Clin Transplant; 2004 Dec; 2(2):273-9. PubMed ID: 15859941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nutritional and intestinal effects of the novel immunosuppressive agents: deoxyspergualin, rapamycin, and mycophenolate mofetil.
    Yanchar NL; Fedorak RN; Kneteman NM; Sigalet DL
    Clin Biochem; 1996 Aug; 29(4):363-9. PubMed ID: 8828967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphological and biochemical effects of immunosuppressive drugs in a capillary tube assay for endothelial dysfunction.
    Wilasrusmee C; Da Silva M; Singh B; Siddiqui J; Bruch D; Kittur S; Wilasrusmee S; Kittur DS
    Clin Transplant; 2003; 17 Suppl 9():6-12. PubMed ID: 12795661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamics of the immunosuppressive effects of the combination of tacrolimus with mycophenolate mofetil.
    Barten MJ; Rahmel A; Richter M; Tarnok A; Bartsch P; Boeger M; Gehlhaar P; Dhein S; Mohr FW; Gummert JF
    Transplant Proc; 2002 Sep; 34(6):2372-3. PubMed ID: 12270442
    [No Abstract]   [Full Text] [Related]  

  • 9. Tacrolimus and mycophenolate mofetil provide effective immunosuppression in rat laryngeal transplantation.
    Nelson M; Fritz M; Dan O; Worley S; Strome M
    Laryngoscope; 2003 Aug; 113(8):1308-13. PubMed ID: 12897551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of sirolimus, tacrolimus and mycophenolate mofetil on osteoclastogenesis--implications for post-transplantation bone disease.
    Westenfeld R; Schlieper G; Wöltje M; Gawlik A; Brandenburg V; Rutkowski P; Floege J; Jahnen-Dechent W; Ketteler M
    Nephrol Dial Transplant; 2011 Dec; 26(12):4115-23. PubMed ID: 21622987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunomodulatory drugs cyclosporin A, mycophenolate mofetil, and sirolimus (rapamycin) inhibit allergen-induced proliferation and IL-5 production by PBMCs from atopic asthmatic patients.
    Powell N; Till S; Bungre J; Corrigan C
    J Allergy Clin Immunol; 2001 Dec; 108(6):915-7. PubMed ID: 11742267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroregeneration in composite tissue allografts: effect of low-dose FK506 and mycophenolate mofetil immunotherapy.
    Cottrell BL; Perez-Abadia G; Onifer SM; Magnuson DS; Burke DA; Grossi FV; Francois CG; Barker JH; Maldonado C
    Plast Reconstr Surg; 2006 Sep; 118(3):615-23; discussion 624-5. PubMed ID: 16932168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinically significant drug interactions with new immunosuppressive agents.
    Mignat C
    Drug Saf; 1997 Apr; 16(4):267-78. PubMed ID: 9113494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of immunosuppressive drugs on in vitro neogenesis of human islets: mycophenolate mofetil inhibits the proliferation of ductal cells.
    Gao R; Ustinov J; Korsgren O; Otonkoski T
    Am J Transplant; 2007 Apr; 7(4):1021-6. PubMed ID: 17391142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tacrolimus with mycophenolate mofetil or sirolimus compared with calcineurin inhibitor-free immunosuppression (sirolimus/mycophenolate mofetil) after heart transplantation: 5-year results.
    Kaczmarek I; Zaruba MM; Beiras-Fernandez A; Reimann R; Nickel T; Grinninger C; Sadoni S; Hagl C; Meiser B
    J Heart Lung Transplant; 2013 Mar; 32(3):277-84. PubMed ID: 23415313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunology in clinical practice. VI. Current immunosuppressive drugs].
    ten Berge RJ; Schellekens PT
    Ned Tijdschr Geneeskd; 1997 Nov; 141(47):2289-92. PubMed ID: 9550813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nocardial infection in a renal transplant recipient on tacrolimus and mycophenolate mofetil.
    Magee CC; Halligan RD; Milford EL; Sayegh MH
    Clin Nephrol; 1999 Jul; 52(1):44-6. PubMed ID: 10442495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive evaluation of immunosuppressive drug efficacy on acute donor cell survival.
    Gheysens O; Lin S; Cao F; Wang D; Chen IY; Rodriguez-Porcel M; Min JJ; Gambhir SS; Wu JC
    Mol Imaging Biol; 2006; 8(3):163-70. PubMed ID: 16555032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tacrolimus and mycophenolate mofetil associations: Induction of oxidative stress or antioxidant effect?
    Ferjani H; Achour A; Bacha H; Abid S
    Hum Exp Toxicol; 2015 Nov; 34(11):1119-32. PubMed ID: 25645822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunosuppressive agents--advances of the developmental studies and the mode of action].
    Ochiai T; Isono K; Gunji Y; Nagata M
    Nihon Rinsho; 1991 Jun; 49(6):1436-41. PubMed ID: 1715926
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.